Primary Site >> Colorectal Cancer
Gene >> EPO
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors. PMID: 8448084 |
Ref: Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells. PMID: 8761303 |
Ref: Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer. PMID: 9469326 |
Ref: Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis. PMID: 16288305 |
Ref: Detection of deregulated pathways to lymphatic metastasis in oral squamous cell carcinoma. PMID: 18802791 Ref: Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells. PMID: 19265263 Ref: [Sport and health]. PMID: 19718895 Ref: Relationships of P53 and Bak with EPO and EPOR in human colorectal cancer. PMID: 19846965 Ref: Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis. PMID: 19877886 |
Ref: Darbepoetin-alpha enhances hepatectomy-associated stimulation of colorectal liver metastatic growth. PMID: 20531003 Ref: GLUT1 and Bcl-xL in relation to erythropoietin in human colorectal adenocarcinomas. PMID: 21033220 |
Ref: Downregulation of erythropoietin receptor by overexpression of phospholipase C-gamma 1 is critical for decrease on focal adhesion in transformed cells. PMID: 21360263 Ref: Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis. PMID: 21623073 |
Ref: Preoperative administration of erythropoietin stimulates tumor recurrence after surgical excision of colon cancer in mice by a vascular endothelial growth factor-independent mechanism. PMID: 23348072 Ref: The relationships between hypoxia-dependent markers: HIF-1alpha, EPO and EPOR in colorectal cancer. PMID: 24497137 |
Ref: The feasibility and clinical efficacy of intravenous iron administration for preoperative anaemia in patients with colorectal cancer. PMID: 24916374 |
Ref: Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts. PMID: 27543111 Ref: Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions? PMID: 27959268 |
Ref: Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production. PMID: 29078273 |
Ref: Simultaneous use of erythropoietin and LFM-A13 as a new therapeutic approach for colorectal cancer. PMID: 29160911 Ref: Erythropoietin Intensifies the Proapoptotic Activity of LFM-A13 in Cells and in a Mouse Model of Colorectal Cancer. PMID: 29690619 |